Med Life - Public Comps and Valuation Multiples

Med Life Overview

About Med Life

Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.

Founded

1996

HQ

Employees

2.5K+

Website

medlife.ro

Sectors

Hospitals & Clinics

Financials

LTM Revenue $698M

LTM EBITDA $103M

EV

$1.4B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Med Life Financials

As of September 2025, Med Life reported last 12-month revenue of $698M and EBITDA of $103M.

In the same period, Med Life generated $583M in LTM gross profit and $15.0M in net income.

See Med Life valuation multiples based on analyst estimates

Med Life P&L

In the most recent fiscal year, Med Life reported revenue of $627M and EBITDA of $89.5M.

Med Life expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Med Life valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$698M	XXX	$627M	XXX	XXX	XXX
Gross Profit	$583M	XXX	$511M	XXX	XXX	XXX
Gross Margin	83%	XXX	82%	XXX	XXX	XXX
EBITDA	$103M	XXX	$89.5M	XXX	XXX	XXX
EBITDA Margin	15%	XXX	14%	XXX	XXX	XXX
EBIT	$42.0M	XXX	$35.0M	XXX	XXX	XXX
EBIT Margin	6%	XXX	6%	XXX	XXX	XXX
Net Profit	$15.0M	XXX	$5.9M	XXX	XXX	XXX
Net Margin	2%	XXX	1%	XXX	XXX	XXX
Net Debt	XXX	XXX	$287M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Med Life including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $698M. EBITDA for the last twelve months was $103M. In the most recent fiscal year, Med Life achieved $627M in revenue and $89.5M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$698M	Analyst estimates available to subscribers	$627M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$583M	Analyst estimates available to subscribers	$511M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	83.5% gross margin	Analyst estimates available to subscribers	81.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$103M	Analyst estimates available to subscribers	$89.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	14.7% EBITDA margin	Analyst estimates available to subscribers	14.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$42.0M	Analyst estimates available to subscribers	$35.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	6.0% EBIT margin	Analyst estimates available to subscribers	5.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$15.0M	Analyst estimates available to subscribers	$5.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	2.1% net profit margin	Analyst estimates available to subscribers	0.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$287M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Med Life

This financial data table provides comprehensive performance metrics for Med Life, a company based in Romania. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Med Life generated $698M in revenue over the last twelve months.
The company achieved $103M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $583M.
Net income over the last twelve months reached $15.0M.

Fiscal Year Performance

In the most recent fiscal year, Med Life reported $627M in total revenue.
Fiscal year EBITDA was $89.5M.
The company maintained a gross profit margin of 81.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 14.3%.
Net profit margin reached 0.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Med Life. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Med Life Stock Performance

Med Life has current market cap of RON 4.4B (or $1.0B), and EV of RON 6.1B (or $1.4B).

Market Cap Evolution

Med Life Stock Data

As of October 3, 2025, Med Life's stock price is RON 8 (or $2).

See Med Life trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.4B	$1.0B	XXX	XXX	XXX	XXX	$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Med Life Valuation Multiples

Med Life's trades at 2.2x EV/Revenue multiple, and 15.7x EV/EBITDA.

See valuation multiples for Med Life and 15K+ public comps

Med Life Financial Valuation Multiples

As of October 3, 2025, Med Life has market cap of $1.0B and EV of $1.4B.

Equity research analysts estimate Med Life's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Med Life has a P/E ratio of 67.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.0B	XXX	$1.0B	XXX	XXX	XXX
EV (current)	$1.4B	XXX	$1.4B	XXX	XXX	XXX
EV/Revenue	2.0x	XXX	2.2x	XXX	XXX	XXX
EV/EBITDA	13.7x	XXX	15.7x	XXX	XXX	XXX
EV/EBIT	33.5x	XXX	40.2x	XXX	XXX	XXX
EV/Gross Profit	2.4x	XXX	n/a	XXX	XXX	XXX
P/E	67.2x	XXX	170.4x	XXX	XXX	XXX
EV/FCF	88.9x	XXX	216.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Med Life Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Med Life Margins & Growth Rates

Med Life's last 12 month revenue growth is 12%

Med Life's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Med Life's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Med Life's rule of X is 46% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Med Life and other 15K+ public comps

Med Life Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	12%	XXX	13%	XXX	XXX	XXX
EBITDA Margin	15%	XXX	14%	XXX	XXX	XXX
EBITDA Growth	30%	XXX	30%	XXX	XXX	XXX
Rule of 40	25%	XXX	27%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	46%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	76%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial